The clinical results of patients stratified with ARB medication at randomization.
收藏NIAID Data Ecosystem2026-03-07 收录
数据链接：
官方服务：
资源简介：
*ARB: Angiotensin II type I receptor blocker. Percent changes of UACR: calculated by level of UACR at each visit compared to level of baseline. Final value: mean value of UACR at 12 weeks and 16 weeks. Secondary outcome: levels of UACR or UPCR at 16 weeks compared to level of baseline. Baseline value: mean value of UACR or UPCR at screening period and randomization period (0 week).
创建时间：
2013-08-19
